On Air Now

Listen

Listen Live Now » 98.5 FM Battle Creek, Michigan

Weather

Current Conditions(Battle Creek,MI 49017)

More Weather »
51° Feels Like: 51°
Wind: NNW 12 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Showers Late 44°

Tomorrow

AM Rain 60°

Sat Night

Mostly Clear 39°

Alerts

AstraZeneca signs deal on cancer drugs with Immunocore

LONDON (Reuters) - AstraZeneca has signed a deal with private British biotech company Immunocore to boost its experimental cancer drug pipeline as it seeks to find new medicines to replace those going off patent.

Immunocore is developing drugs known as "ImmTACs" that exploit the power of the body's own immune system to find and kill diseased cells.

AstraZeneca said on Wednesday its MedImmune unit would pay Immunocore $20 million upfront per program and the biotech firm would then be eligible to get up to $300 million in development and commercial milestone payments for each target program, plus royalties on any eventual sales.

(Reporting by Ben Hirschler)

Comments